Skip to main content
Top
Published in: Journal of Diabetes & Metabolic Disorders 2/2020

01-12-2020 | Research article

Attenuating properties of Rubus fruticosus L. on oxidative damage and inflammatory response following streptozotocin-induced diabetes in the male Wistar rats

Authors: Naser Mirazi, Abdolkarim Hosseini

Published in: Journal of Diabetes & Metabolic Disorders | Issue 2/2020

Login to get access

Abstract

Purpose

Diabetes mellitus is a prevalent metabolic disorder that entails numerous complications in various organs. In current era, different types of diseases are being treated by the applications of herbs. The present study is aimed at investigating the anti-inflammatory and antioxidant effects of the Rubus fruticosus hydroethanolic extracts (RFHE) in the streptozotocin (STZ)-induced diabetic rats.

Methods

At this experimental research, male Wistar rats with the weight of 220 ± 20 g, were categorized randomly into five groups of vehicles as control, STZ (60 mg kg− 1 of body weight, intraperitoneally (i.p.)) and RFHE (50, 100 and 200 mg kg− 1, i.p.). In the last stage (end of week 4) of the experiment, after being euthanized, the blood samples of the rats were collected for measuring malondialdehyde (MDA), glutathione (GSH), total antioxidant status (TAS) as well as inflammatory markers like tumor necrosis factor (TNF)-α, interleukin (IL)-6 and C-reactive protein (CRP).

Results

Data from this study was revealed that diabetes causes oxidative damage and consequently the serum level of inflammatory markers rises. RFHE was shown to be significantly correlated with lowering the level of MDA, TNF-α, IL-6 and CRP of diabetic rats. Moreover, RFHE significantly elevated the GSH and TAS serum levels in diabetic rats when compared with STZ group.

Conclusions

RFHE might have anti-diabetic properties; this outcome may be mediated by high antioxidant and anti-inflammatory effects.
Literature
2.
go back to reference Larejani B, Zahedi F. Epidemiology of diabetes mellitus in Iran. Iran J Diabetes Lipid Disord. 2001;1(1):1–8. Larejani B, Zahedi F. Epidemiology of diabetes mellitus in Iran. Iran J Diabetes Lipid Disord. 2001;1(1):1–8.
3.
go back to reference Meraci M, Feizi A, Bagher Nejad M. Investigating the prevalence of high blood pressure, type 2 diabetes mellitus and related risk factors according to a large general study in Isfahan- using multivariate logistic regression model. Health Syst Res. 2012;8(2). Meraci M, Feizi A, Bagher Nejad M. Investigating the prevalence of high blood pressure, type 2 diabetes mellitus and related risk factors according to a large general study in Isfahan- using multivariate logistic regression model. Health Syst Res. 2012;8(2).
4.
go back to reference Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabetic Med. 1997;14(Suppl 5):1–85. Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabetic Med. 1997;14(Suppl 5):1–85.
8.
go back to reference Mohajeri D, Doustar Y, Rezaei A, Mesgari Abbasi M. Hepatoprotective Effect of ethanolic extract of Crocus sativus L. (saffron) stigma in comparison with silymarin against rifampin induced hepatotoxicity in rats. Zahedan J Res Med Sci. 2011;12:53–9. Mohajeri D, Doustar Y, Rezaei A, Mesgari Abbasi M. Hepatoprotective Effect of ethanolic extract of Crocus sativus L. (saffron) stigma in comparison with silymarin against rifampin induced hepatotoxicity in rats. Zahedan J Res Med Sci. 2011;12:53–9.
11.
go back to reference Gomar A, Hosseini A, Mirazi N. Preventive effect of Rubus fruticosus on learning and memory impairment in an experimental model of diabetic neuropathy in male rats. Pharma Nutr. 2014;2(4):155–60. Gomar A, Hosseini A, Mirazi N. Preventive effect of Rubus fruticosus on learning and memory impairment in an experimental model of diabetic neuropathy in male rats. Pharma Nutr. 2014;2(4):155–60.
12.
go back to reference Beutler E, Duron O, Kelly BM. Improved method for the determination of blood glutathione. J Lab Clin Med. 1963;61:882–8.PubMed Beutler E, Duron O, Kelly BM. Improved method for the determination of blood glutathione. J Lab Clin Med. 1963;61:882–8.PubMed
21.
go back to reference Ma H, Johnson SL, Liu W, DaSilva NA, Meschwitz S, Dain JA, et al. Evaluation of polyphenol anthocyanin-enriched extracts of blackberry, black raspberry, blueberry, cranberry, red raspberry, and strawberry for free radical scavenging, reactive carbonyl species trapping, anti-glycation, anti-β-amyloid aggregation, and microglial neuroprotective effects. Int J Mol Sci. 2018;19(2):461. https://doi.org/10.3390/ijms19020461. CrossRefPubMedCentral Ma H, Johnson SL, Liu W, DaSilva NA, Meschwitz S, Dain JA, et al. Evaluation of polyphenol anthocyanin-enriched extracts of blackberry, black raspberry, blueberry, cranberry, red raspberry, and strawberry for free radical scavenging, reactive carbonyl species trapping, anti-glycation, anti-β-amyloid aggregation, and microglial neuroprotective effects. Int J Mol Sci. 2018;19(2):461. https://​doi.​org/​10.​3390/​ijms19020461. CrossRefPubMedCentral
23.
go back to reference Abdu D, Majeed SNJJAC. Identification of antioxidant compounds in red raspberry (Rubus idaeus) fruit in Kurdistan region (North Iraq). 2012;2(3):6–10. Abdu D, Majeed SNJJAC. Identification of antioxidant compounds in red raspberry (Rubus idaeus) fruit in Kurdistan region (North Iraq). 2012;2(3):6–10.
Metadata
Title
Attenuating properties of Rubus fruticosus L. on oxidative damage and inflammatory response following streptozotocin-induced diabetes in the male Wistar rats
Authors
Naser Mirazi
Abdolkarim Hosseini
Publication date
01-12-2020
Publisher
Springer International Publishing
Published in
Journal of Diabetes & Metabolic Disorders / Issue 2/2020
Electronic ISSN: 2251-6581
DOI
https://doi.org/10.1007/s40200-020-00649-3

Other articles of this Issue 2/2020

Journal of Diabetes & Metabolic Disorders 2/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.